Overview of drugs approved by the FDA in 2022

Overview of drugs approved by the FDA in 2022

The aim of the work is to conduct a review of medications approved by the FDA in 2022.Materials and methods. In searching for the materials to write this review article, bibliographic databases including PubMed, Google Scholar and e-library.ru were utilized. The search was conducted for the publicat...

Full description

Saved in:
Bibliographic Details
Main Authors: D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, Yu. V. Gorbunova, Yu. A. Kolosov, M. A. Dzhavakhyan, I. E. Makarenko, R. V. Drai, A. V. Zaborovsky, O. V. Shatalova, A. V. Strygin, V. I. Petrov, A. P. Pleten, A. A. Prokopov, T. Yu. Tatarenko-Kozmina
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2023-11-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
fda
biopharmaceuticals
monoclonal antibodies
drug design trends
Online Access:https://www.pharmpharm.ru/jour/article/view/1353
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.pharmpharm.ru/jour/article/view/1353

Similar Items